Howard A. "Skip" Burris III, MD
Medical Oncologist
Tennessee Oncology PLLC
President, Clinical Operations & CMO
Sarah Cannon
1100 Charlotte Ave., Suite 800
Nashville 37203
615.329.7274
tnoncology.com
sarahcannon.com

In his roles with Sarah Cannon, HCA's global cancer institute, Burris leads clinical strategy and drug development, which includes overseeing physician-led, patient-centric integrated cancer services. In 1997, Burris established the first community-based phase I drug development program in Nashville, which became Sarah Cannon Research Institute. Burris has led first-in-human studies for many now-approved drugs that have changed the standard of care and was named a 'Giant of Cancer Care' at the 2014 American Society of Clinical Oncology's annual meeting. He received his medical degree from the University of South Alabama and performed his residency and fellowship in hematology/oncology at Brooke Army Medical Center in San Antonio, Texas.